This is fascinating. The claim is an enzyme has a domain unrelated to its main binding site that (accidentally?) regulates transcription of genes implicated in Alzheimer’s. Binding that domain with a small molecule can inhibit its role in advancing the disease. scitechdaily.com/scientists-di ht @nedhamson1